Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer-Reference-Cited by-同舟云学术

Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer

Published:2016-08-23 Issue:8 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Cheuk Daniel KL¹,Sieswerda Elske²,van Dalen Elvira C²,Postma Aleida³,Kremer Leontien CM²

Affiliation:

1. The University of Hong Kong, Queen Mary Hospital; Department of Pediatrics and Adolescent Medicine; Pokfulam Road Hong Kong China

2. Emma Children's Hospital/Academic Medical Center; Department of Paediatric Oncology; PO Box 22660 Amsterdam Netherlands 1100 DD

3. University Medical Center Groningen and University of Groningen, Beatrix Children's Hospital; Department of Paediatric Oncology; Postbus 30.000 Groningen Netherlands 9700 RB

Publisher

Wiley

Subject

Pharmacology (medical)

Reference74 articles.

1. Clinical analysis of Sodium phosphocreatine on cardiac toxicity induced by anthracycline antibiotics in acute leukemia children;Chen;Chinese Journal of Cancer Prevention and Treatment,2008

2. Optimal multivariate matching before randomization;Greevy;Biostatistics,2004

3. Randomization inference with imperfect compliance in the ACE-inhibitor after anthracycline randomized trial;Greevy;Journal of the American Statistical Association,2004

4. Challenges in conducting a pediatric longitudinal prevention study: lessons from the ACE-inhibitor after anthracycline trial;Silber;Progress in Pediatric Cardiology,2005

5. The role of afterload reduction in the prevention of late anthracycline cardiomyopathy;Silber;Pediatric Blood & Cancer,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An evidence gap map of interventions for noncommunicable diseases and risk factors among children and adolescents;Nature Medicine;2024-01

2. Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group;The Lancet Oncology;2023-03

3. Diagnosis and Management of Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Children;Children;2023-01-12

4. Preventive strategies of cancer therapeutics-related cardiotoxicity in childhood cancer survivors: a protocol of systematic review;BMJ Open;2022-09

5. Cancer treatment-related cardiac dysfunction;BMJ Supportive & Palliative Care;2022-07-26